Cargando…
A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability
RET, BRAF and other protein kinases have been identified as major molecular players in thyroid cancer. To identify novel kinases required for the viability of thyroid carcinoma cells, we performed a RNA interference screening in the RET/PTC1(CCDC6-RET)-positive papillary thyroid cancer cell line TPC...
Autores principales: | Cantisani, Maria Carmela, Parascandolo, Alessia, Perälä, Merja, Allocca, Chiara, Fey, Vidal, Sahlberg, Niko, Merolla, Francesco, Basolo, Fulvio, Laukkanen, Mikko O., Kallioniemi, Olli Pekka, Santoro, Massimo, Castellone, Maria Domenica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053742/ https://www.ncbi.nlm.nih.gov/pubmed/27058903 http://dx.doi.org/10.18632/oncotarget.8577 |
Ejemplares similares
-
A dual mechanism of activation of the Sonic Hedgehog pathway in anaplastic thyroid cancer: crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stroma
por: Parascandolo, Alessia, et al.
Publicado: (2017) -
Human α-L-fucosidase-1 attenuates the invasive properties of thyroid cancer
por: Vecchio, Giancarlo, et al.
Publicado: (2017) -
High-Throughput 3D Screening Reveals Differences in Drug Sensitivities between Culture Models of JIMT1 Breast Cancer Cells
por: Hongisto, Vesa, et al.
Publicado: (2013) -
Identification of MicroRNAs Inhibiting TGF-β-Induced IL-11 Production in Bone Metastatic Breast Cancer Cells
por: Pollari, Sirkku, et al.
Publicado: (2012) -
High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer
por: Vainio, Paula, et al.
Publicado: (2012)